Real-World Safety and Efficacy of SGLT2 Inhibitors in Elderly Type 2 Diabetic Patients

被引：0
|
作者：
Trescoli, Carlos
Fajardo, Carmen
Aranzo, Jose
Trescoli, Ana
Garcia, Mar
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2368-PUB
引用
收藏
页码：A595 / A595
页数：1
相关论文
共 50 条
  • [1] Safety of SGLT2 inhibitors in elderly patients with diabetic kidney disease
    Reactions Weekly, 2023, 1964 (1) : 11 - 11
  • [2] Real-World Study on the Effect of SGLT2 Inhibitors in Patients with Type 2 Diabetes in China
    Xue, Yaoming
    Shi, Lixin
    Yu, Xuefeng
    Wang, Yangang
    Hong, Tianpei
    Li, Xiaoying
    Ma, Jianhua
    Zhu, Dalong
    Mu, Yiming
    DIABETES, 2024, 73
  • [3] A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
    Liu, Allen Yan Lun
    Low, Serena
    Yeoh, Ester
    Lim, Eng Kuang
    Renaud, Claude Jeffrey
    Teoh, Selene Tse Yen
    Tan, Grace Feng Ling
    Chai, Chung Cheen
    Liu, Bo
    Subramaniam, Tavintharan
    Sum, Chee Fang
    Lim, Su Chi
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1403 - 1414
  • [4] Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
    Su Jin Jeong
    Seung Eun Lee
    Dong Hyun Shin
    Ie Byung Park
    Hui Seung Lee
    Kyoung-Ah Kim
    BMC Nephrology, 22
  • [5] Efficacy and Safety of SGLT2 Inhibitors in Patients with a LVAD
    Preheim, E.
    Straw, L.
    Mardis, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S647 - S647
  • [6] Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study
    Jeong, Su Jin
    Lee, Seung Eun
    Shin, Dong Hyun
    Park, Ie Byung
    Lee, Hui Seung
    Kim, Kyoung-Ah
    BMC NEPHROLOGY, 2021, 22 (01)
  • [7] Real-world efficacy and safety of SGLT2 inhibitors in type 1 diabetes: a two-center cohort retrospective study
    van Nes, F.
    Palanca, A.
    Ampudia-Blasco, F.
    Pardo, F.
    Real, J.
    Mathieu, C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 259 - 260
  • [8] First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors
    Schanz, Moritz
    Seikrit, Claudia
    Hohenstein, Bernd
    Zimmermann, Aline
    Kraft, Leonie
    Schricker, Severin
    Berger, Susann
    Schwab, Andrea
    Oberacker, Tina
    Latus, Joerg
    CLINICAL KIDNEY JOURNAL, 2025, 18 (01)
  • [9] The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes
    Tosaki, Takahiro
    Kamiya, Hideki
    Kato, Yoshiro
    Kondo, Masaki
    Nakamura, Jiro
    DIABETES, 2015, 64 : A154 - A155
  • [10] First Real-World Evidence of Sparsentan Efficacy in Patients with IgA Nephropathy Treated with SGLT2 Inhibitors
    Schanz, Moritz
    Schricker, Severin
    Schwab, Andrea
    Latus, Joerg
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345